These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 35116879)
21. Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer. Chen SS; Li K; Wu J; Peng ZY; Wang ZD; Wang JC; Xu CW; Zhu CL; Li BC; Ren H; Tang SC; Sun X J Cancer Res Clin Oncol; 2021 Jan; 147(1):223-233. PubMed ID: 32691153 [TBL] [Abstract][Full Text] [Related]
22. Autoantibodies against tumor-associated antigens in the early detection of lung cancer. Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer. Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480 [TBL] [Abstract][Full Text] [Related]
24. [Early diagnosis of subtype in early clinical stage lung adenocarcinoma by using an autoantibody panel and computed tomography]. Meng QC; Gao PR; Ren PF; Song YP; Li HL Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(3):204-208. PubMed ID: 30669764 [No Abstract] [Full Text] [Related]
25. Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer. Wang T; Liu H; Pei L; Wang K; Song C; Wang P; Ye H; Zhang J; Ji Z; Ouyang S; Dai L Clin Immunol; 2020 Jan; 210():108262. PubMed ID: 31629809 [TBL] [Abstract][Full Text] [Related]
26. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma. Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067 [TBL] [Abstract][Full Text] [Related]
27. Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients. Shih NY; Lai HL; Chang GC; Lin HC; Wu YC; Liu JM; Liu KJ; Tseng SW Jpn J Clin Oncol; 2010 Jul; 40(7):663-9. PubMed ID: 20395242 [TBL] [Abstract][Full Text] [Related]
28. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis. Tang ZM; Ling ZG; Wang CM; Wu YB; Kong JL PLoS One; 2017; 12(7):e0182117. PubMed ID: 28750095 [TBL] [Abstract][Full Text] [Related]
29. Serum anti-MDM2 and anti-c-Myc autoantibodies as biomarkers in the early detection of lung cancer. Li P; Shi JX; Dai LP; Chai YR; Zhang HF; Kankonde M; Kankonde P; Yu BF; Zhang JY Oncoimmunology; 2016 May; 5(5):e1138200. PubMed ID: 27467958 [TBL] [Abstract][Full Text] [Related]
30. A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer. Hong CQ; Weng XF; Huang XC; Chu LY; Wei LF; Lin YW; Chen LY; Liu CT; Xu YW; Peng YH J Cancer; 2021; 12(9):2747-2755. PubMed ID: 33854634 [TBL] [Abstract][Full Text] [Related]
31. Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer. Qiu C; Duan Y; Wang B; Shi J; Wang P; Ye H; Dai L; Zhang J; Wang X Front Immunol; 2021; 12():698312. PubMed ID: 34489945 [TBL] [Abstract][Full Text] [Related]
32. Stem signatures associating SOX2 antibody helps to define diagnosis and prognosis prediction with esophageal cancer. Peng ZY; Wang QS; Li K; Chen SS; Li X; Xiao GD; Tang SC; Ren H; Wang Z; Sun X Ann Med; 2022 Dec; 54(1):921-932. PubMed ID: 35382656 [TBL] [Abstract][Full Text] [Related]
33. A Diagnostic Model With IgM Autoantibodies and Carcinoembryonic Antigen for Early Detection of Lung Adenocarcinoma. Zhang X; Li J; Wang Y; Liu M; Liu F; Zhang X; Pei L; Wang T; Jiang D; Wang X; Zhang J; Dai L Front Immunol; 2021; 12():728853. PubMed ID: 35140701 [TBL] [Abstract][Full Text] [Related]
34. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma. Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295 [TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of α-enolase expression and serum α-enolase autoantibody levels in lung cancer. Zhang L; Wang H; Dong X J Bras Pneumol; 2018; 44(1):18-23. PubMed ID: 29538538 [TBL] [Abstract][Full Text] [Related]
36. Serum anti-p53 antibodies in patients with lung cancer. Mack U; Ukena D; Montenarh M; Sybrecht GW Oncol Rep; 2000; 7(3):669-74. PubMed ID: 10767388 [TBL] [Abstract][Full Text] [Related]
37. Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patients. Cressey R; Pimpa S; Chewaskulyong B; Lertprasertsuke N; Saeteng S; Tayapiwatana C; Kasinrerk W BMC Biotechnol; 2008 Feb; 8():16. PubMed ID: 18284706 [TBL] [Abstract][Full Text] [Related]
38. Detection of Novel Autoantibodies to Nucleolin's RNA-binding Domains as a Serum Tumor Biomarker Through ELISA. Ezzatifar F; Rafiei A; Valadan R; Asgarian-Omran H; Jeddi-Tehrani M Iran J Allergy Asthma Immunol; 2022 Dec; 21(6):616-625. PubMed ID: 36640053 [TBL] [Abstract][Full Text] [Related]
39. Discovering novel lung cancer associated antigens and the utilization of their autoantibodies in detection of lung cancer. Pei L; Liu H; Ouyang S; Zhao C; Liu M; Wang T; Wang P; Ye H; Wang K; Song C; Zhang J; Dai L Immunobiology; 2020 Mar; 225(2):151891. PubMed ID: 31839396 [TBL] [Abstract][Full Text] [Related]
40. Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer. Mitsudomi T; Suzuki S; Yatabe Y; Nishio M; Kuwabara M; Gotoh K; Hatooka S; Shinoda M; Suyama M; Ogawa M; Takahashi T; Ariyoshi Y; Takahashi T J Natl Cancer Inst; 1998 Oct; 90(20):1563-8. PubMed ID: 9790550 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]